NASDAQ : PODD
Insulet Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 149.68 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 10.38B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 10.38B |
| Enterprise Value | 10.86B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 69.35M |
| Shares Outstanding | 69.35M |
| Shares Change (YoY) | -1.19% |
| Shares Change (QoQ) | -1.14% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 103.41% |
| Float | 69.06M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 28.26 |
| Forward PE | 21.68 |
| PS Ratio | 3.40 |
| Forward PS | 2.97 |
| PB Ratio | 7.30 |
| P/TBV Ratio | 8.27 |
| P/FCF Ratio | 35.35 |
| P/OCF Ratio | 20.31 |
| PEG Ratio | 1.09 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 28.94 |
| EV / Sales | 3.56 |
| EV / EBITDA | 17.66 |
| EV / EBIT | 21.07 |
| EV / FCF | 36.98 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.48 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 1.62 |
| Debt / FCF | 3.46 |
| Interest Coverage | 8.77 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 26.02% |
| Return on Assets (ROA) | 9.71% |
| Return on Invested Capital (ROIC) | 20.92% |
| Return on Capital Employed (ROCE) | 21.30% |
| Weighted Average Cost of Capital (WACC) | 9.78% |
| Revenue Per Employee | $565,444 |
| Profits Per Employee | $69,500 |
| Employee Count | 5,400 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 1.90 |
Taxes
| Measure | Value |
|---|
| Income Tax | 119.40M |
| Effective Tax Rate | 24.14% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -52.66% |
| 50-Day Moving Average | 140.91 |
| 200-Day Moving Average | 178.80 |
| Relative Strength Index (RSI) | 62.35 |
| Average Volume (20 Days) | 1,388,982 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.63M |
| Short Previous Month | 5.36M |
| Short % of Shares Out | 8.12% |
| Short % of Float | 8.15% |
| Short Ratio (days to cover) | 3.51 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.05B |
| Gross Profit | 2.17B |
| Operating Income | 515.60M |
| Pretax Income | 494.70M |
| Net Income | 375.30M |
| EBITDA | 614.90M |
| EBIT | 515.60M |
| Earnings Per Share (EPS) | $5.30 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 534.90M |
| Total Debt | 1.02B |
| Net Cash | -480.60M |
| Net Cash Per Share | -$6.93 |
| Equity (Book Value) | 1.42B |
| Book Value Per Share | 20.51 |
| Working Capital | 1.10B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 511.20M |
| Capital Expenditures | -217.50M |
| Depreciation & Amortization | 99.30M |
| Net Borrowing | -609.00M |
| Free Cash Flow | 293.70M |
| FCF Per Share | $4.23 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.07% |
| Operating Margin | 16.89% |
| Pretax Margin | 16.20% |
| Profit Margin | 12.29% |
| EBITDA Margin | 20.14% |
| EBIT Margin | 16.89% |
| FCF Margin | 9.62% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.19% |
| Shareholder Yield | 1.19% |
| Earnings Yield | 3.54% |
| FCF Yield | 2.83% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $167.17 |
| Price Target Difference | 11.69% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 15.98% |
| EPS Growth Forecast (3Y) | 22.83% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 8.46 |
| Piotroski F-Score | 8 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |